TEST BANK FOR Advanced Practice Nursing
in the Care of Older Adults, 3rd Edition
by Laurie Kennedy-Malone, Verified Chapters 1 - 23, Complete
,Answers52at52the52end52of52the52Chapter
Chapter 1: Changes with Aging
52 52 52 52
Multiple52Choice
Identify52the52choice52that52best52completes52the52statement52or52answers52the52question.
1. The52major52impact52of52the52physiological52changes52that52occur52with52aging52is:
A. Reduced52physiological52reserve
B. Reduced52homeostatic52 mechanisms
C. Impaired52immunological52response
D. All52of52the52above
2. The52strongest52evidence52regarding52normal52physiological52aging52is52available52through:
,A. Randomized52controlled52clinical52trials
B. Cross-sectional52studies
C. Longitudinal52studies
D. Case52control52studies
3. All52of52the52following52statements52are52true52about52labo
ratory52values52in52older52adultsexcept:
A. Reference52ranges52are52preferable
B. Abnormal52findings52are52often52due52to52physiological52aging
C. Normal52ranges52may52not52be52applicable52for52older52adults
D. Reference52values52are52not52necessarily52acceptable52values
4. Biochemical52individuality52is52best52described52as:
A. Each52individual’s52variation52is52often52much52greater52than52that52of52a52larger52group
B. The52unique52biochemical52profile52of52a52selected52population
C. The52truly52“normal”52individual—falling52within52average52range
D. Each52individual’s52variation52is52often52much52smaller52than52that52of52a52larger52group
5. Polypharmacy52ois52obest52odescribed52oas52otaking:
A. More52othan52onine52omedications52oper52oday
B. Moreothan52ofive52omedications52oper52oday
, C. Even52oa52osingle52omedication52oif52othere52ois52onot52oa52oclear52oindication52ofor52oits52ouse
D. When52oa52odrug52ois52ogiven52oto52otreat52othe52oside52oeffect52oof52oanother52odrug
52o52o5 2 o 6.52o52 Pharmacokinetic52ochanges52owithoaging52ois52oreflective52oof:
A. What52othe52odrug52odoes52oto52othe52obody
B. What52othe52obody52odoes52oto52othe52odrug
C. The52oeffect52oat52othe52osite52oof52oaction52oand52othe52otime52oand52ointensity52oof52othe52odrug
D. The52oside52oeffects52ocommonly52oassociated52owith52othe52odrug
52o52o5 2 o
7.5 2 o52All52othe52ofollowing52ostatements52oare52ofalse52oabout52odrug52oabsorption52oexcept
:
A. Antacids52oincrease52othe52obioavailability52oof52odigitalis
B. Gastric52oacidity52odecreases52owith52oage
C. Anticholinergics52oincrease52ocolonic52omotility
D. Underlying52ochronic52odisease52ohas52olittle52oimpact52oon52odrug52oabsorption
52o52o5 2 o
8.52o52All52oof52othe52ofollowing52ostatements52oare52otrue52oabout52odrug52odistributio
n52oin52othe52elderly52oexcept:
A. Drugs52odistributed52oin52owater52ohave52olower52oconcentration
B. Drugs52odistributed52oin52ofat52ohave52oless52ointense,52omore52oprolonged52oeffect
C. Drugs52ohighly52oprotein52obound52ohave52ogreater52opotential52oto52ocauseoan52oadverse52odrug52oreaction
in the Care of Older Adults, 3rd Edition
by Laurie Kennedy-Malone, Verified Chapters 1 - 23, Complete
,Answers52at52the52end52of52the52Chapter
Chapter 1: Changes with Aging
52 52 52 52
Multiple52Choice
Identify52the52choice52that52best52completes52the52statement52or52answers52the52question.
1. The52major52impact52of52the52physiological52changes52that52occur52with52aging52is:
A. Reduced52physiological52reserve
B. Reduced52homeostatic52 mechanisms
C. Impaired52immunological52response
D. All52of52the52above
2. The52strongest52evidence52regarding52normal52physiological52aging52is52available52through:
,A. Randomized52controlled52clinical52trials
B. Cross-sectional52studies
C. Longitudinal52studies
D. Case52control52studies
3. All52of52the52following52statements52are52true52about52labo
ratory52values52in52older52adultsexcept:
A. Reference52ranges52are52preferable
B. Abnormal52findings52are52often52due52to52physiological52aging
C. Normal52ranges52may52not52be52applicable52for52older52adults
D. Reference52values52are52not52necessarily52acceptable52values
4. Biochemical52individuality52is52best52described52as:
A. Each52individual’s52variation52is52often52much52greater52than52that52of52a52larger52group
B. The52unique52biochemical52profile52of52a52selected52population
C. The52truly52“normal”52individual—falling52within52average52range
D. Each52individual’s52variation52is52often52much52smaller52than52that52of52a52larger52group
5. Polypharmacy52ois52obest52odescribed52oas52otaking:
A. More52othan52onine52omedications52oper52oday
B. Moreothan52ofive52omedications52oper52oday
, C. Even52oa52osingle52omedication52oif52othere52ois52onot52oa52oclear52oindication52ofor52oits52ouse
D. When52oa52odrug52ois52ogiven52oto52otreat52othe52oside52oeffect52oof52oanother52odrug
52o52o5 2 o 6.52o52 Pharmacokinetic52ochanges52owithoaging52ois52oreflective52oof:
A. What52othe52odrug52odoes52oto52othe52obody
B. What52othe52obody52odoes52oto52othe52odrug
C. The52oeffect52oat52othe52osite52oof52oaction52oand52othe52otime52oand52ointensity52oof52othe52odrug
D. The52oside52oeffects52ocommonly52oassociated52owith52othe52odrug
52o52o5 2 o
7.5 2 o52All52othe52ofollowing52ostatements52oare52ofalse52oabout52odrug52oabsorption52oexcept
:
A. Antacids52oincrease52othe52obioavailability52oof52odigitalis
B. Gastric52oacidity52odecreases52owith52oage
C. Anticholinergics52oincrease52ocolonic52omotility
D. Underlying52ochronic52odisease52ohas52olittle52oimpact52oon52odrug52oabsorption
52o52o5 2 o
8.52o52All52oof52othe52ofollowing52ostatements52oare52otrue52oabout52odrug52odistributio
n52oin52othe52elderly52oexcept:
A. Drugs52odistributed52oin52owater52ohave52olower52oconcentration
B. Drugs52odistributed52oin52ofat52ohave52oless52ointense,52omore52oprolonged52oeffect
C. Drugs52ohighly52oprotein52obound52ohave52ogreater52opotential52oto52ocauseoan52oadverse52odrug52oreaction
